2 weeks Ago By Defense World Staff
Forsta AP Fonden reduced its position in shares of Teleflex Incorporated ( NYSE:TFX – Free Report ) by 50.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,100 shares of the medical technology company’s stock after selling 5,200 shares during the quarter.
Forsta AP Fonden’s holdings in Teleflex were worth $1,073,000 as of its most recent SEC filing. Other institutional investors have also recently modified their holdings of the company. International Assets Investment Management LLC grew its holdings in Teleflex by 20,300.
0% in the fourth quarter. International Assets Investment Management LLC now owns 2,244 shares of the medical technology company’s stock valued at $560,000 after purchasing an additional 2,233 shares during the period. Dimensional Fund Advisors LP raised its position in Teleflex by 8.
2% during the fourth quarter. Dimensional Fund Advisors LP now owns 356,532 shares of the medical technology company’s stock worth $88,900,000 after acquiring an additional 27,048 shares during the period. Envestnet Portfolio Solutions Inc.
lifted its holdings in Teleflex by 5.6% during the fourth quarter. Envestnet Portfolio Solutions Inc.
now owns 1,489 shares of the medical technology company’s stock valued at $371,000 after purchasing an additional 79 shares in the last quarter. Boston Partners acquired a new stake in shares of Teleflex in the fourth quarter valued at about $343,000. Finally, Quadrant Capital Group LLC increased its stake in shares of Teleflex by 67.
2% during the fourth quarter. Quadrant Capital Group LLC now owns 229 shares of the medical technology company’s stock worth $57,000 after purchasing an additional 92 shares in the last quarter. 95.
62% of the stock is currently owned by institutional investors and hedge funds. Teleflex Stock Performance NYSE TFX opened at $245.90 on Tuesday.
Teleflex Incorporated has a fifty-two week low of $177.63 and a fifty-two week high of $257.85.
The firm has a market capitalization of $11.58 billion, a P/E ratio of 39.47, a price-to-earnings-growth ratio of 2.
20 and a beta of 1.16. The stock’s fifty day moving average is $233.
60 and its two-hundred day moving average is $219.95. The company has a debt-to-equity ratio of 0.
36, a quick ratio of 1.44 and a current ratio of 2.58.
Teleflex Announces Dividend The company also recently declared a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were issued a dividend of $0.34 per share.
The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.
55%. Teleflex’s dividend payout ratio is currently 21.83%.
Analyst Ratings Changes TFX has been the topic of a number of research reports. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their price target for the company from $205.00 to $245.
00 in a research note on Monday, July 1st. Stephens lifted their price target on Teleflex from $275.00 to $290.
00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. Royal Bank of Canada increased their price objective on Teleflex from $235.00 to $260.
00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Finally, Truist Financial lifted their target price on shares of Teleflex from $240.00 to $247.
00 and gave the stock a “hold” rating in a research note on Monday, August 5th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $265.
57. Check Out Our Latest Report on Teleflex Insider Activity In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction on Friday, August 16th.
The stock was sold at an average price of $238.93, for a total transaction of $638,898.82.
Following the completion of the sale, the director now owns 5,496 shares of the company’s stock, valued at $1,313,159.28. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink .
Corporate insiders own 1.43% of the company’s stock. About Teleflex ( Free Report ) Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. Recommended Stories Five stocks we like better than Teleflex Transportation Stocks Investing Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible Trading Stocks: RSI and Why it’s Useful Roblox’s Growth Beyond Kids: Stock Set for Major Moves How to Calculate Stock Profit 5 Oversold Stocks to Buy Right Now Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated ( NYSE:TFX – Free Report ).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter ..
